<prompt> Akaretsa sehlooho le morero oa sehlooho sena.  <response>: Instruction in English: Summarize the main topic and purpose of this article. . Response in English: The article discusses the potential for implementing artificial intelligence AI in clinical trials to improve efficiency and accelerate drug development. Researchers at Kings College London have developed an AI platform that can predict whether a patient will enroll in a clinical trial, which may help to improve recruitment, reduce costs and speed up drug development. The platform achieved 85 accuracy in predicting patient participation, and its success sets the stage for further exploration of the role of AI in clinical trials. . Response in Sesotho: Sengoliloeng se bua ka monyetla oa ho kenya tsebetsong bohlale ba maiketsetso AI litekong tsa bongaka ho ntlafatsa tsebetso le ho potlakisa ntsetsopele ea lithethefatsi. Bafuputsi ba Kings College London ba thehile sethala sa AI se ka bolelang esale pele hore na mokuli o tla ingolisa tekong ea bongaka, e ka thusang ho ntlafatsa khiro, ho fokotsa litšenyehelo le ho potlakisa ntsetsopele ea lithethefatsi. Sethala se fihletse ho nepahala ha 85 ho bolela esale pele ho kenya letsoho ha mokuli, me katleho ea eona e beha mohato oa ho hlahloba ka ho eketsehileng karolo ea AI litekong tsa meriana. 